CLOV stock forecast remains in focus for swing traders as RSI patterns approach oversold territory. Should institutional buying increase, upside could reach $1.65 in near-term projections. Clover Health Investments' significant individual investors ownership suggests that the key decisions are influenced by shareholders from the larger public Overall CLOV ranks 6th on our list of the best penny stock to buy for 2025. While we acknowledge the potential of CLOV as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than CLOV but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock . CLOV stock forecast is adjusted for inflation expectations and interest rate changes. Under a mild recession scenario, valuations remain resilient around $1.50, outperforming certain healthcare peers.
